Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols

被引：13

作者：

Kim, Callain Y. ^{[1
]}

Mahaney, Paige E. ^{[1
]}

McConnell, Oliver ^{[1
]}

Zhang, Yingru ^{[1
]}

Manas, Eric ^{[1
]}

Ho, Douglas M. ^{[2
]}

Deecher, Darlene C. ^{[1
]}

Trybulski, Eugene J. ^{[1
]}

机构：

[1] Wyeth Res, Chem Sci, Collegeville, PA 19426 USA

[2] Princeton Univ, Dept Chem, Princeton, NJ 08543 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 17期

关键词：

Vasomotor symptoms; Monoamine reuptake inhibitor; Norepiephrine reuptake inhibitor; NRI; NE; 5-HT; ENANTIOMERIC SEPARATION; CHIRAL TECHNOLOGY; NOREPINEPHRINE; ANTIDEPRESSANT; REBOXETINE; EFFICACY;

D O I：

10.1016/j.bmcl.2009.07.053

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols, have been discovered by combining virtual and focused screening efforts with design techniques. Synthesis of the two diastereomeric isomers of the molecule followed by chiral resolution of each enantiomer revealed the (2R,3S)-isomer to be a potent norepinephrine reuptake inhibitor (IC50 = 28 nM) with excellent selectivity over the dopamine transporter and 13-fold selectivity over the serotonin transporter. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：5029 / 5032

页数：4

共 50 条

[21] Crystal structure of 3-(adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-[(E)-(2,6-difluorobenzylidene)amino]-1H-1,2,4-triazole-5(4H)-thione, C31H36F2N6S
Al-Alshaikh, Monirah A.
Ghabbour, Hazem A.
Abuelizz, Hatem A.
Alruqi, Obaid S.
El-Emam, Ali A.
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2016, 231 (03): : 927 - 929
[22] Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl) pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT1A receptor and SERT
Wrobel, Martyna Z.
Chodkowski, Andrzej
Dawidowski, Maciej
Siwek, Agata
Stachowicz, Katarzyna
Szewczyk, Bernadeta
Nowak, Gabriel
Satala, Grzegorz
Bojarski, Andrzej J.
Turlo, Jadwiga
BIOORGANIC CHEMISTRY, 2023, 141
[23] 5-(1-Aryl-3-(thiophen-2-yl)-1H-pyrazo1-4-yl)-1H-tetrazoles: Synthesis, structural characterization, Hirshfeld analysis, anti-inflammatory and anti-bacterial studies
Kumbar, Mahadev N.
Kamble, Ravindra R.
Dasappa, Jagadeesh Prasad
Bayannavar, Praveen K.
Khamees, Hussien Ahmed
Mahendra, M.
Joshi, Shrinivas D.
Dodamani, Suneel
Rasal, V. P.
Jalalpure, Sunil
JOURNAL OF MOLECULAR STRUCTURE, 2018, 1160 : 63 - 72
[24] Discovery of a Novel Glucagon Receptor Antagonist N-[(4-{(1S)-1-[3-(3, 5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the Treatment of Type II Diabetes
Xiong, Yusheng
Guo, Jian
Candelore, Mari R.
Liang, Rui
Miller, Corey
Dallas-Yang, Qing
Jiang, Guoqiang
McCann, Peggy E.
Qureshi, Sajjad A.
Tong, Xinchun
Xu, Shiyao Sherrie
Shang, Jackie
Vincent, Stella H.
Tota, Laurie M.
Wright, Michael J.
Yang, Xiaodong
Zhang, Bei B.
Tata, James R.
Parmee, Emma R.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (13) : 6137 - 6148
[25] 6-[2-(4-aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones:: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors
Bromidge, Steven M.
Bertani, Barbara
Borriello, Manuela
Faedo, Stefania
Gordon, Laurie J.
Granci, Enrica
Hill, Matthew
Marshall, Howard R.
Stasi, Luigi P.
Zucchelli, Valeria
Merlo, Giancarlo
Vesentini, Alessia
Watson, Jeannette M.
Zonzini, Laura
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5653 - 5656
[26] Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist
De Savi, Chris
Bradbury, Robert H.
Rabow, Alfred A.
Norman, Richard A.
de Almeida, Camila
Andrews, David M.
Ballard, Peter
Buttar, David
Callis, Rowena J.
Currie, Gordon S.
Curwen, Jon O.
Davies, Chris D.
Donald, Craig S.
Feron, Lyman J. L.
Gingell, Helen
Glossop, Steven C.
Hayter, Barry R.
Hussain, Syeed
Karoutchi, Galith
Lamont, Scott G.
MacFaul, Philip
Moss, Thomas A.
Pearson, Stuart E.
Tonge, Michael
Walker, Graeme E.
Weir, Hazel M.
Wilson, Zena
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (20) : 8128 - 8140
[27] Convenient Synthesis of New N-3-Substituted Pyrido[1,2:1,5]pyrazolo[3,4-d]pyrimidine-2,4(1H,3H)-dione Derivatives
Belaroussi, Rabia
El Bouakher, Abderrahman
Marchivie, Mathieu
Massip, Stephane
Jarry, Christian
El Hakmaoui, Ahmed
Guillaumet, Gerald
Routier, Sylvain
Akssira, Mohamed
SYNTHESIS-STUTTGART, 2013, 45 (18): : 2557 - 2566
[28] Discovery and in vitro and in vivo profiles of N-ethyl-N-[2-[3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl]ethyl]-2-(2H-1,2,3-triazol-2-yl)-benzamide as a novel class of dual orexin receptor antagonist
Suzuki, Ryo
Nozawa, Dai
Futamura, Aya
Nishikawa-Shimono, Rie
Abe, Masahito
Hattori, Nobutaka
Ohta, Hiroshi
Araki, Yuko
Kambe, Daiji
Ohmichi, Mari
Tokura, Seiken
Aoki, Takeshi
Ohtake, Norikazu
Kawamoto, Hiroshi
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (06) : 1260 - 1275
[29] Studies towards the next generation of antidepressants.: Part 4:: Derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor
Evrard, DA
Zhou, P
Yi, SY
Zhou, DH
Smith, DL
Sullivan, KM
Hornby, GA
Schechter, LE
Andree, TH
Mewshaw, RE
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (04) : 911 - 914
[30] Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152)
O'Neill, David J.
Adedoyin, Adedayo
Bray, Jenifer A.
Deecher, Darlene C.
Fensome, Andrew
Goldberg, Joel A.
Harrison, Jim
Leventhal, Liza
Mann, Charles
Mark, Lilly
Nogle, Lisa
Sullivan, Nicole R.
Spangler, Taylor B.
Terefenko, Eugene A.
Trybulski, Eugene J.
Uveges, Albert J.
Vu, An
Whiteside, Garth T.
Zhang, Puwen
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (19) : 6824 - 6831

← 1 2 3 4 5 →